A Metabolomics-Based Biomarker Signature Discriminates Pancreatic Cancer From Chronic Pancreatitis

Gut - United Kingdom
doi 10.1136/gutjnl-2016-313665
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Chronic Pancreatitis and Pancreatic Cancer

Gastroenterology
HepatologyGastroenterology
2014English

Inflammation and Cancer v. Chronic Pancreatitis and Pancreatic Cancer

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2004English

Metabolomics a Novel Biomarker in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2013English

A Clinical Metabolomics‑based Biomarker Signature as an Approach for Early Diagnosis of Gastric Cardia Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Pancreatic Enzyme Replacement Therapy in the Course of Chronic Pancreatitis and Pancreatic Cancer

Effective Pharmacotherapy
2019English

A Panel of 13-miRNA Signature as a Potential Biomarker for Predicting Survival in Pancreatic Cancer

Oncotarget
Oncology
2016English

PRSS1 Intron Mutations in Patients With Pancreatic Cancer and Chronic Pancreatitis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2011English

Type 3c (Pancreatogenic) Diabetes Mellitus Secondary to Chronic Pancreatitis and Pancreatic Cancer

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy